The investments are part of the near-term $1.5B R&I pipeline of expected new projects previously announced by Ventas.
The projects are 40% pre-leased and are expected to generate more than 7% cash yield and more than an 8% GAAP yield, upon stabilization.
The new projects include:
A new research, academic medicine an innovation hub in relationship with University of Pittsburgh to house immunotherapy research in collaboration with the University of Pittsburgh Medical Center and co-located with UPMC's Shadyside Hospital;
A new development that expands Philadelphia uCity Square Knowledge Communitiy associated with the University of Pennsylvania;
Also in uCity Square, a College of Nursing and Health Professionals for Drexel University; and
Expansion of Cortex Innovation Community associated with Washington University in St. Louis.
Now read: 99 Blooming May S&P 500 Stocks »
Subscribe for full text news in your inbox